Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm - first patient dosed in USA under FDA approved EAP

Feb 18, 2020 at 3:33 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment